Preliminary results from the AACR 2025 Annual Meeting reveal encouraging clinical responses to the investigational oral agent ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

A Whangārei retiree funding his own targeted cancer therapy is frustrated that he has to spend more than $25,000 on GST alone ...

Williams, 70, has to pay nearly $180,000 for his cancer therapy, of which more than $25,000 will go on GST. “It’s a tax on ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

Multicenter study sponsored by SELNET to evaluate cirtuvivint as a second-line monotherapy in selected sarcoma subtypes. SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Biosplice Ther ...

For the first quarter, total revenues increased 9% to $8.1 billion in comparison to the first quarter of 2024. Product sales grew 11%, primarily driven by 14% ...

Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontline therapies. A team of Mass General Brigham researchers found ...

Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomasRelapsed/refractory (R/R ...

It’s not good to take zinc supplements for long periods of time, especially every day. If you take too much zinc for ...

We recently published a list of 13 Most Profitable Growth Stocks to Buy Now. In this article, we are going to take a look at ...